STOCK OPTIONS (Details Narrative) - USD ($) |
3 Months Ended | 6 Months Ended | |||
|---|---|---|---|---|---|
Jun. 30, 2025 |
Jun. 30, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
Feb. 09, 2023 |
|
| Class of Warrant or Right [Line Items] | |||||
| Compensation expense | $ 40,750 | $ 22,403 | $ 122,807 | $ 115,122 | |
| Aggregate intrinsic value, exercisable | 35,227,743 | 35,227,743 | |||
| Estimated fair value of common stock | $ 0.001 | ||||
| Warrant [Member] | |||||
| Class of Warrant or Right [Line Items] | |||||
| Compensation expense | $ 389,179 | $ 394,418 | $ 778,359 | $ 785,165 | |
| Future compensation cost | $ 271,815 | $ 271,815 | |||
| Aggregate intrinsic value, exercisable | 0 | 0 | |||
| Estimated fair value of common stock | $ 0.03 | $ 0.03 | |||
| X | ||||||||||
- Definition Class of warrant of right exercisable warrants. No definition available.
|
| X | ||||||||||
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of cost not yet recognized for nonvested award under share-based payment arrangement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|